Boris Nikolic
◆ Investment Thesis
The firm’s investment thesis centers on using data, computation, and advanced biology to transform healthcare and life sciences. It backs companies in genomics, synthetic biology, diagnostics, medical devices, and digital health, with a clear bias toward scientific platforms and technologies that can produce outsized impact in medicine and biology.[1][2]
◆ About Boris Nikolic
Boris Nikolic is a biotechnology-focused venture investor associated with Biomatics Capital, which invests at the intersection of life sciences and computation. The firm’s emphasis appears to be on genomics, synthetic biology, digital health, and AI-enabled drug discovery rather than broad software or consumer investing.[1][2]
◆ Sectors
◆ Stages
◆ Geography Focus
◆ FAQ
What does Boris Nikolic invest in?
Boris Nikolic invests in Biotech at the seed stage.
Which geographies does Boris Nikolic focus on?
Boris Nikolic focuses on United States, and is headquartered in United States.